Okay. Just to clarify, I don't think a letter hurts, but it's not the powerful tool that we're making it out to be. This is all happening. It's all in the process. If the vice-chairs get together and put together a letter today, maybe that's the easiest way to do it expeditiously. It doesn't hurt, but it's not a powerful tool.
I'll tell you why it's happening. Ms. Bennett mentioned JDRF. They're not competing with JDRF. JDRF actually got the funding for the artificial pancreas clinical trials. As you will recall, there was a press conference on it a year ago. It's being done through the Federal Economic Development Agency for Southern Ontario. The clinical trials are occurring right now in Waterloo and Hamilton with $25 million. So they're not competing with JDRF and I don't want us to fear that.
What Alain Beaudet said very clearly was it shouldn't be limited to $10 million. What if we have more than $10 million in applications? Don't set an arbitrary figure. That said, if you only have $6 million in credible applications, why take $4 million out of the pool?